Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6534609 | 6453988 | F | 6534609-6 | 20070801 | 20100107 | 20100112 | EXP | B0492380A | GLAXOSMITHKLINE | 39 | YR | F | Y | 45 | KG | 20100112 | CN | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6534609 | 1012931605 | PS | LAMIVUDINE | 2 | UNKNOWN | 300MG PER DAY | 20564 | ||||
| 6534609 | 1012931606 | SS | NEVIRAPINE | 1 | ORAL | 400MG PER DAY | |||||
| 6534609 | 1012931607 | SS | VIDEX | 1 | ORAL | 400MG PER DAY |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6534609 | 1012931605 | HIV INFECTION |
| 6534609 | 1012931606 | HIV INFECTION |
| 6534609 | 1012931607 | HIV INFECTION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6534609 | HO |
| 6534609 | LT |
| 6534609 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6534609 | ABDOMINAL DISTENSION |
| 6534609 | CONSTIPATION |
| 6534609 | LACTASE DEFICIENCY |
| 6534609 | MITOCHONDRIAL TOXICITY |
| 6534609 | PORTAL VEIN THROMBOSIS |
| 6534609 | SEPSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6534609 | 1012931605 | 20011201 | 20070926 | ||
| 6534609 | 1012931606 | 20011201 | 20070926 | ||
| 6534609 | 1012931607 | 20010101 | 20070926 |